News
Pfizer’s COVID-19 Vaccine And Drug Sale To Top $50 Billion in 2022
Drugmaker, Pfizer has reported having more than double of annual profits due to its sales of vaccines in 2021, forecasting that the company will make more than $50 billion in 2022 for its Covid-19 vaccine and therapeutic.
Pfizer, whose vaccine developed with German company BioNTech wand as the first approved in the United States to counter the deadly covid-19 virus, sees slightly lower 2022 revenues for the vaccine compared with the just-finished year.
Chief Executive Albert Bourla described 2021 as a “watershed year” for Pfizer, adding that the company’s efforts in the pandemic “have fundamentally changed our company forever.”
Besides vaccines, sales were mixed across Pfizer’s other divisions. Revenues dipped for internal medicine and inflammation and immunology, but rose for oncology, hospitals and rare disease.
For 2022, Pfizer expects $32 billion in revenue from Covid-19 vaccines and $22 billion in revenues from Paxlovid.
The results show how covid has transformed Pfizer, which a year ago had projected just $15 billion in Covid-19 vaccines sales in 2021 and ended up selling more than twice that amount after repeatedly lifting the forecast.
Bourla said the company is currently working on a new vaccine candidate based on the Omicron variant of Covid-19, as well as a new “potential next-generation oral Covid-19 treatment.”
Pfizer says it expects to produce 120 million treatment courses for Paxlovid, with six million in the first quarter and 30 million the first half of 2022.
Bourla said the sales for Paxlovid “could be way bigger” than current forecasts. The 2022 estimate of $22 billion is based on signed contracts and negotiations where
there is essentially an agreement, he said.
Bourla said the company’s scientists “continue to monitor the Covid-19 virus and believe it is unlikely that it will be fully eradicated in the foreseeable future.”
“That said, we now have the tools — in the forms of vaccines and treatments — that we believe will help enable us to not only better manage the pandemic but also help countries move into the endemic phase,” he said.
The renewed agreement reinforces the longstanding partnership between the artist and the label. It positions Chadreek for the next phase of his career with enhanced support across music production, distribution, marketing, and international expansion.
Known for his smooth vocal delivery and consistent output, Chadreek has steadily cultivated a dedicated following through standout records including Ori Mi (featuring Seyi Vibez), Better Dayz, Awure, and his earlier project No Bad Vibe. The renewed deal is expected to accelerate his momentum as he prepares new music and broadens his presence across Africa and global markets.
A source close to the camp confirmed that both parties are fully aligned on a clear vision for the artist’s next chapter, with a strong emphasis on high-quality releases and strategic growth.
This renewal marks another significant milestone in Chadreek’s journey as he continues to establish his place within the Afrobeats landscape.
About Chadreek
Chadreek is a Nigerian singer and songwriter signed to SauceBoi Music. He is recognised for his distinctive voice and a growing catalogue of Afrobeats records that blend melody, emotion, and street energy.
About SauceBoi Music
SauceBoi Music is a UK-based record label committed to developing and promoting talent across the Afrobeats and broader African music scenes.
Josh2Funny’s Album Has Fans Talking — But Should He Stick To Music Or Skits? 😂🎶
Nigerian comedian and content creator Josh2Funny has taken his comedy game into music, and Nigerians are definitely having something to say about it.
The comedian released his 15-track album, “On Behalf of Josh,” on July 10, 2026, but instead of fading away after release, the project has continued to generate conversations on X.
And the big question now is:
Should Josh2Funny continue with music or go back to skits? 😂
Fans have been divided. While some listeners openly criticized the album and told him to return to comedy, others found songs they genuinely enjoyed.
One X user joked:
“Josh2Funny stopped doing skits and started music, Everybody wan chop this music money 😂”
Another simply said:
“This Josh2Funny Album no enter make he just go back skit abeg 😂”
But then came “Lembe.” 🔥
The track caught fire on X and eventually became a trending topic in Nigeria. The #LembeChallenge also gained momentum as creators began jumping on the song.
Josh2Funny later announced ₦1 million for winners of the challenge, giving the song another major push.
And it didn’t stop there.
‘INTERNATIONAL’ FT. ICE PRINCE ALSO TRENDED
On another day, “International” featuring Ice Prince generated its own buzz on X.
One fan even called it their favourite song from the album, while praising the collaboration. The post itself pulled thousands of views, showing that people weren’t only talking about Lembe.
From album criticism to trending songs and challenges, “On Behalf of Josh” has kept Josh2Funny’s name in the conversation.
Whether you love the album or think he should return to skits, one thing is clear:
Josh2Funny has succeeded in getting Nigerians talking. 😂🔥
So, let’s settle this once and for all:
Should Josh2Funny continue with MUSIC 🎶 or return to SKITS 😂?
Music or Skits? Drop your answer! 👇
-
Audio10 years agoPage – Day Break Everywhere Burst
-
Audio5 years agoShadykarz – Forever
-
Audio10 years agoJuniorboy ft. 9ice – IRAPADA
-
Entertainment Gists6 years agoEx-Beauty Queen, Sandra Benede Shares Sexy Photo
-
Audio5 years agoSimi – Happy Birthday ft. Adekunle Gold, DeJa
-
Audio5 years agoRuger – Bounce
-
Mixtapes4 years agoMixtape: DJ DimpleNipple – The Best Of Amapiano Thrills
-
Editorials3 years agoSa’eedah Imam On Creating Her Imprint In The Nigerian Music Industry As An Emerging Creative Writer